1.4M XNAS Volume
XNAS 21 Mar, 2025 5:30 PM (EDT)
Board Meeting
The next board meeting for Nektar Therapeutics is on 27 Mar 2025 for the purpose of H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference 2025
See details
Low Financial Strength
Expensive Valuation
Technically Neutral
Momentum Trap
These stocks are the ones with poor quality and also financials and technical ranging from bad to medium score. This indicates that investors should be highly watchful with these stocks.
View Similar
Embed DVM
Nektar Therapeutics Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..